Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001535610-17-000005
Filing Date
2017-01-05
Accepted
2017-01-05 16:22:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 SABBY 13G-A CRXM 1.05.17 crxm0117.txt SC 13G/A 11705
  Complete submission text file 0001535610-17-000005.txt   13607
Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121
Business Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121 (858) 436-1000
Taxus Cardium Pharmaceuticals Group Inc. (Subject) CIK: 0000772320 (see all company filings)

EIN.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-51647 | Film No.: 17510995
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458
Business Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458 646-307-4527
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A